Assembly Biosciences
ASMB
37 hedge funds and large institutions have $26.7M invested in Assembly Biosciences in 2013 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 15 closing their positions.
4% more capital invested
Capital invested by funds: $25.6M → $26.7M (+$1.11M)
14% less funds holding
Funds holding: 43 → 37 (-6)
30% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 10
40% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 15
60% less call options, than puts
Call options by funds: $49K | Put options by funds: $121K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
+$102K |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$99.6K |
| 3 |
FNYS
First New York Securities
New York
|
+$99.6K |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$82K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$78K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.67M |
| 2 |
SC
Sophrosyne Capital
New York
|
-$925K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$273K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$246K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$203K |
ASMB Hedge Fund Activity: Q3 2013 in Review
37 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q3 2013, worth a combined $26.7M — up 4.3% from $25.6M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of ASMB and 9 opened new positions — a net loss of 6 holders — while 10 trimmed existing stakes and 7 added.
The largest buyer was DRW Securities, opening a new position worth an estimated $102K. The largest seller was Sabby Management, exiting entirely with an estimated $1.67M sold.
- 37 institutional investors held Assembly Biosciences (ASMB) as of Q3 2013, down from 43 in Q2 2013.
- Funds reported $26.7M of Assembly Biosciences stock for Q3 2013, up 4.3% quarter-over-quarter.
- 9 funds opened new Assembly Biosciences positions in Q3 2013 and 15 closed out, a net change of -6 holders.
- The largest Assembly Biosciences buyer in Q3 2013 was DRW Securities, an estimated $102K added.
- The largest Assembly Biosciences seller in Q3 2013 was Sabby Management, an estimated $1.67M sold.
Based on aggregated 13F filings for Q3 2013.